Your browser doesn't support javascript.
loading
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.
Schröder, Fritz H; Hugosson, Jonas; Roobol, Monique J; Tammela, Teuvo L J; Zappa, Marco; Nelen, Vera; Kwiatkowski, Maciej; Lujan, Marcos; Määttänen, Liisa; Lilja, Hans; Denis, Louis J; Recker, Franz; Paez, Alvaro; Bangma, Chris H; Carlsson, Sigrid; Puliti, Donella; Villers, Arnauld; Rebillard, Xavier; Hakama, Matti; Stenman, Ulf-Hakan; Kujala, Paula; Taari, Kimmo; Aus, Gunnar; Huber, Andreas; van der Kwast, Theo H; van Schaik, Ron H N; de Koning, Harry J; Moss, Sue M; Auvinen, Anssi.
Afiliación
  • Schröder FH; Department of Urology, Erasmus University Medical Center, Rotterdam, Netherlands. Electronic address: secr.schroder@erasmusmc.nl.
  • Hugosson J; Department of Urology, Sahlgrenska Academy at Goteborg University, Goteborg, Sweden.
  • Roobol MJ; Department of Urology, Erasmus University Medical Center, Rotterdam, Netherlands.
  • Tammela TL; Department of Urology, Tampere University Hospital, Tampere, Finland; School of Medicine, University of Tampere, Tampere, Finland.
  • Zappa M; Unit of Clinical and Descriptive Epidemiology, ISPO, Florence, Italy.
  • Nelen V; Provinciaal Instituut voor Hygiene, Antwerp, Belgium.
  • Kwiatkowski M; Department of Urology, Kantonsspital Aarau, Aarau, Switzerland; Department of Urology, Academic Hospital Braunschweig, Braunschweig, Germany.
  • Lujan M; Department of Urology, Hospital Infanta Cristina, Parla, Madrid, Spain; Department of Urology, Hospital Universitario de Getafe, Getafe, Madrid, Spain; Universidad Complutense de Madrid, Madrid, Spain.
  • Määttänen L; Finnish Cancer Registry, Helsinki, Finland.
  • Lilja H; Department of Surgery (Urology), Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Departments of Laboratory Medicine and Medicine (GU-Oncology), Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK; Department
  • Denis LJ; Oncology Centre Antwerp, Antwerp, Belgium.
  • Recker F; Department of Urology, Kantonsspital Aarau, Aarau, Switzerland.
  • Paez A; Department of Urology, Hospital Universitario de Fuenlabrada, Madrid, Spain; Department of Urology, Hospital Universitario de Getafe, Getafe, Madrid, Spain; Universidad Rey Juan Carlos, Madrid, Spain.
  • Bangma CH; Department of Urology, Erasmus University Medical Center, Rotterdam, Netherlands.
  • Carlsson S; Department of Urology, Sahlgrenska Academy at Goteborg University, Goteborg, Sweden; Department of Surgery (Urology), Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Puliti D; Unit of Clinical and Descriptive Epidemiology, ISPO, Florence, Italy.
  • Villers A; Department of Urology, CHU Lille, Univ Lille Nord de France, Lille, France.
  • Rebillard X; Service d'Urologie, Clinique BeauSoleil, Montpellier, France.
  • Hakama M; Finnish Cancer Registry, Helsinki, Finland; School of Health Sciences, University of Tampere, Tampere, Finland.
  • Stenman UH; Department of Clinical Chemistry, Helsinki University Central Hospital Laboratory Division (HUSLAB), Helsinki, Finland.
  • Kujala P; FIMLAB, Department of Pathology, Tampere, Finland.
  • Taari K; Department of Urology, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland.
  • Aus G; Department of Urology, Carlanderska Sjukhuset Göteborg, Sweden.
  • Huber A; Centre of Laboratory Medicine, Kantonsspital Aarau, Aarau, Switzerland.
  • van der Kwast TH; Department of Pathology, Erasmus University Medical Center, Rotterdam, Netherlands.
  • van Schaik RH; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, Netherlands.
  • de Koning HJ; Department of Public Health, Erasmus University Medical Center, Rotterdam, Netherlands.
  • Moss SM; Centre for Cancer Prevention, Queen Mary University of London, London, UK.
  • Auvinen A; School of Health Sciences, University of Tampere, Tampere, Finland.
Lancet ; 384(9959): 2027-35, 2014 Dec 06.
Article en En | MEDLINE | ID: mdl-25108889
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Lancet Año: 2014 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Lancet Año: 2014 Tipo del documento: Article Pais de publicación: Reino Unido